» Articles » PMID: 32961738

Selection of Cryoprotectant in Lyophilization of Progesterone-Loaded Stearic Acid Solid Lipid Nanoparticles

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2020 Sep 23
PMID 32961738
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Cryoprotectants are often required in lyophilization to reduce or eliminate agglomeration of solute or suspended materials. The aim of this study was to select a cryoprotecting agent and optimize its concentration in a solid lipid nanoparticle formulation. Progesterone-loaded stearic acid solid lipid nanoparticles (SA-P SLNs) were prepared by hot homogenization with high speed mixing and sonication. The stearic acid content was 4.6% and progesterone was 0.46% of the initial formulation. Multiple surfactants were evaluated, and a lecithin and sodium taurocholate system was chosen. Three concentrations of surfactant were then evaluated, and a concentration of 2% was chosen based on particle size, polydispersity, and zeta potential. Agglomeration of SA-P SLNs after lyophilization was observed as measured by increased particle size. Dextran, glycine, mannitol, polyvinylpyrrolidone (PVP), sorbitol, and trehalose were evaluated as cryoprotectants by both an initial freeze-thaw analysis and after lyophilization. Once selected as the cryoprotectant, trehalose was evaluated at 5%, 10%, 15%, and 20% for optimal concentration, with 20% trehalose being finally selected as the level of choice. Evaluation by DSC confirmed intimate interaction between stearic acid and progesterone in the SA-P SLNs, and polarized light microscopy shows successful lyophilization of the trehalose/SA-P SLN. A short term 28-day stability study suggests the need for refrigeration of the final lyophilized SA-P SLNs in moisture vapor impermeable packaging.

Citing Articles

Development and Characterization of Lyophilized Chondroitin Sulfate-Loaded Solid Lipid Nanoparticles: Encapsulation Efficiency and Stability.

Bustos Araya M, Ricart A, Calpena Campmany A, Prohens R, Minarro Carmona M Pharmaceutics. 2025; 17(1.

PMID: 39861734 PMC: 11768393. DOI: 10.3390/pharmaceutics17010086.


Development and Optimization of Nano-Hydroxyapatite Encapsulating Tocotrienol-Rich Fraction Formulation Using Response Surface Methodology.

Mohd Zaffarin A, Ng S, Ng M, Hassan H, Alias E Pharmaceutics. 2025; 17(1).

PMID: 39861662 PMC: 11768454. DOI: 10.3390/pharmaceutics17010010.


Optimization of Glyburide-loaded Nanosuspensions Ball Milling and Homogenization Techniques: A Central Composite Design Approach for Enhanced Solubility.

Gungor D, Aytekin E, Akdag Y, Sahin S, Gulsun T Curr Pharm Des. 2024; 31(5):377-390.

PMID: 39313907 DOI: 10.2174/0113816128321501240828054050.


Preparation and Optimization of MiR-375 Nano-Vector Using Two Novel Chitosan-Coated Nano-Structured Lipid Carriers as Gene Therapy for Hepatocellular Carcinoma.

Soliman B, Wen M, Kandil E, El-Agamy B, Gamal-Eldeen A, ElHefnawi M Pharmaceutics. 2024; 16(4).

PMID: 38675155 PMC: 11054685. DOI: 10.3390/pharmaceutics16040494.


HPMCAS-Based Amorphous Solid Dispersions in Clinic: A Review on Manufacturing Techniques (Hot Melt Extrusion and Spray Drying), Marketed Products and Patents.

Corrie L, Ajjarapu S, Banda S, Parvathaneni M, Bolla P, Kommineni N Materials (Basel). 2023; 16(20).

PMID: 37895598 PMC: 10608006. DOI: 10.3390/ma16206616.


References
1.
Borges O, Borchard G, Verhoef J, de Sousa A, Junginger H . Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm. 2005; 299(1-2):155-66. DOI: 10.1016/j.ijpharm.2005.04.037. View

2.
Abdelwahed W, Degobert G, Stainmesse S, Fessi H . Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006; 58(15):1688-713. DOI: 10.1016/j.addr.2006.09.017. View

3.
Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A . Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics. 2018; 10(2). PMC: 6027495. DOI: 10.3390/pharmaceutics10020057. View

4.
Hu F, Hong Y, Yuan H . Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm. 2004; 273(1-2):29-35. DOI: 10.1016/j.ijpharm.2003.12.016. View

5.
Franze S, Selmin F, Samaritani E, Minghetti P, Cilurzo F . Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging. Pharmaceutics. 2018; 10(3). PMC: 6161153. DOI: 10.3390/pharmaceutics10030139. View